Detalles de la búsqueda
1.
Synthesis and Evaluation of in Vivo Anti-hypothermic Effect of the N- and C-Terminus Modified Thyrotropin-Releasing Hormone Mimetic: [(4S,5S)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-[3-(thiazol-4-yl)-L-alanyl]-L-prolinamide.
Chem Pharm Bull (Tokyo)
; 69(4): 314-324, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33790077
2.
Pharmacologic effects of naldemedine, a peripherally acting µ-opioid receptor antagonist, in in vitro and in vivo models of opioid-induced constipation.
Neurogastroenterol Motil
; 31(5): e13563, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30821019
3.
Correction to Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{N-[(4S,5S)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-3-(thiazol-4-yl)-l-alanyl}-(2R)-2-methylpyrrolidine Trihydrate (Rovatirelin Hydrate).
ACS Omega
; 4(4): 6977-6978, 2019 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31459810
4.
Oxycodone-induced analgesic effects in a bone cancer pain model in mice.
Oncology
; 74 Suppl 1: 55-60, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18758199
5.
Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{N-[(4S,5S)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-3-(thiazol-4-yl)-l-alanyl}-(2R)-2-methylpyrrolidine Trihydrate (Rovatirelin Hydrate).
ACS Omega
; 3(10): 13647-13666, 2018 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-30411045
6.
Distinct relations among plasma concentrations required for different pharmacological effects in oxycodone, morphine, and fentanyl.
J Pain Palliat Care Pharmacother
; 25(4): 318-34, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22126163
7.
Morphine, oxycodone, and fentanyl exhibit different analgesic profiles in mouse pain models.
J Pharmacol Sci
; 111(1): 60-72, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19729873
8.
BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild-type mice.
J Neurochem
; 99(6): 1555-63, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17083447
Resultados
1 -
8
de 8
1
Próxima >
>>